Aluztra Bio (Global Intellectual Property for Anagrelide) is Buildings and Property in United Kingdom that focus on Global intellectual property business. They cover business area such as global intellectual property, Anagrelide, side effect, an oral capsule.
-
Global Intellectual Property
-
The Old Rectory, Southampton Road
Landford
Salisbury SP5 2ED
England, United Kingdom
Private
global intellectual propertyAnagrelideside effectan oral capsule
* We use standard office opening hours in near Aluztra Bio (Global Intellectual Property for Anagrelide)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Aluztra Bio (Global Intellectual Property For Anagrelide) is Buildings and Property business from United Kingdom that founded in - ( years old in ), Aluztra Bio (Global Intellectual Property for Anagrelide) business is focusing on Global Intellectual Property.
Aluztra Bio (Global Intellectual Property for Anagrelide) headquarter office and corporate office address is located in The Old Rectory, Southampton Road Landford Salisbury SP5 2ED England, United Kingdom.
Aluztra Bio (Global Intellectual Property for Anagrelide) was founded in United Kingdom.
In , Aluztra Bio (Global Intellectual Property for Anagrelide) is currently focus on Global intellectual property sector.
Above is snippet of Google Trends for "Global intellectual property" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Aluztra Bio (Global Intellectual Property for Anagrelide), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
